Objective
=========

NF-κB is a key regulator of synovial inflammation. In the initiation phase of rheumatoid arthritis (RA) dendritic cells and T cells are likely to be important, whereas in established arthritis other cells play a key role as well. We investigated the relative effect of upstream NF-κB inhibition specifically in T cells versus non-cell type specific NF-κB inhibition in different stages of rat adjuvant arthritis (AA), using either the T-cell specific PKC-theta inhibitory factor (PIF) peptides or non-cell type specific IKK-beta blocking NEMO binding domain (NBD) peptides. The effects of the NBD peptide on human RA synovial tissue in culture were also evaluated.

Methods
=======

AA was induced in Lewis rats by intradermal injection of heat-killed mycobacteria. Rats develop clinical signs of arthritis 10--12 days after immunization. PIF or NBD peptides (150 μg) were administered either intraperitoneally or intra-articularly into the ankle joint at different time-points. The course and severity of arthritis was monitored using water-displacement plethysmometry. On day 21 rats were sacrificed and tissue specimens were collected for routine histology and X-rays of the ankle joints. Human RA synovial tissue was collected by arthroscopy and cultured *ex vivo*± NBD (100 μM). Tumor necrosis factor alpha induced IL-6 production was measured in the supernatant after 7 days by ELISA.

Results
=======

Intra-articular injection of the T-cell specific PKC-theta inhibitor PIF on days 10 and 12 did not result in amelioration of arthritis nor reduced bone erosion. However, intraperitoneal injection of PIF on days -1, 1 and 3 resulted in reduced T-cell proliferation on day 5 in response to TCR triggering (50%; *P*= 0.03) or cognate antigen (PPD) (30%; *P*= 0.05). Furthermore, this resulted in a slightly reduced severity of arthritis (area under the curve 18.47 versus 22.86; *P*= not significant) and radiological damage (erosion score 4 versus 6; *P*= not significant). Non-cell type specific NF-κB blockade by the NBD peptide resulted, however, in significantly reduced severity of arthritis (*P*\< 0.0001) and radiological damage (*P*= 0.04) when injected intra-articularly on days 10 and 12. In addition, proinflammatory cytokine expression was significantly lower in synovial tissue of NBD-treated rats. Incubation of human RA synovial tissue with NBD peptides resulted in 33% inhibition of tumor necrosis factor alpha induced IL-6 production in the supernatant (*P*\< 0.01).

Conclusions
===========

Specific NF-κB blockade using a small molecule inhibitor of IKK beta has anti-inflammatory effects in AA and human RA synovial tissue. Inhibition of PKC-theta has clear effects on T-cell proliferation when administered around the induction of arthritis, but very limited effects on the clinical course of arthritis, suggesting that NF-κB activity in other cell types contributes significantly to the inflammatory response. These results indicate that IKK-beta-targeted NF-κB blockade is superior to T-cell specific PKC-theta inhibition in established arthritis.
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